Bioventus issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
The most recent guidance for Bioventus (BVS) was reported on November 5, 2024 for the full year 2024. The company provided earnings per share guidance in the range of $0.40 to $0.42, compared to the estimated EPS of $0.39. Additionally, Bioventus forecasted revenue between $0.56B and $0.57B for the quarter.
Browse guidance and forecast on all stocks.